Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses (Q28166727)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 12 January 2004)
edit
Language Label Description Also known as
English
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
scientific article (publication date: 12 January 2004)

    Statements

    0 references
    0 references
    Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    Frank M Sacks
    0 references
    Robert P Byington
    0 references
    Donald A Berry
    0 references
    Scott M Berry
    0 references
    Neville F Ford
    0 references
    Andrew J Walker
    0 references
    Kannan Natarajan
    0 references
    Chen Sheng-Lin
    0 references
    Frederick T Fiedorek
    0 references
    Rene Belder
    0 references
    12 January 2004
    0 references
    164
    0 references
    1
    0 references
    40-4
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit